UA105608C2 - Indrikson's method for anticellulite packing - Google Patents
Indrikson's method for anticellulite packingInfo
- Publication number
- UA105608C2 UA105608C2 UAA201310119A UAA201310119A UA105608C2 UA 105608 C2 UA105608 C2 UA 105608C2 UA A201310119 A UAA201310119 A UA A201310119A UA A201310119 A UAA201310119 A UA A201310119A UA 105608 C2 UA105608 C2 UA 105608C2
- Authority
- UA
- Ukraine
- Prior art keywords
- packing
- indrikson
- anticellulite
- medicine
- dermatocosmetology
- Prior art date
Links
- 238000012856 packing Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 240000008574 Capsicum frutescens Species 0.000 abstract 1
- 208000035484 Cellulite Diseases 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010049752 Peau d'orange Diseases 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000001390 capsicum minimum Substances 0.000 abstract 1
- 230000036232 cellulite Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, namely to dermatocosmetology and esthetic medicine and can be used for treating cellulite by packing in the mixture of capsicum, caffeine and the simple moistening cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201310119A UA105608C2 (en) | 2013-08-15 | 2013-08-15 | Indrikson's method for anticellulite packing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201310119A UA105608C2 (en) | 2013-08-15 | 2013-08-15 | Indrikson's method for anticellulite packing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA105608C2 true UA105608C2 (en) | 2014-05-26 |
Family
ID=56267983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201310119A UA105608C2 (en) | 2013-08-15 | 2013-08-15 | Indrikson's method for anticellulite packing |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA105608C2 (en) |
-
2013
- 2013-08-15 UA UAA201310119A patent/UA105608C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015010921A (en) | Carbazole compounds useful as bromodomain inhibitors. | |
| IN2014DN10386A (en) | ||
| MX2015012502A (en) | Dna-pk inhibitors. | |
| MY187540A (en) | Compounds active towards bromodomains | |
| SG10201806867VA (en) | Dll3 modulators and methods of use | |
| HK1220980A1 (en) | Methods and compositions for treatment of pompe disease | |
| WO2015044782A3 (en) | Intranasal dhe for the treatment of headache | |
| MX2016004741A (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent. | |
| MY174991A (en) | Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system | |
| PH12017500348A1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
| TW201613628A (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
| SG10201811078XA (en) | Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions | |
| MX2016008150A (en) | Berberine formulations and uses thereof. | |
| MY191337A (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| MX2015016410A (en) | Esters of oligo-hydroxycarboxylic acids and use thereof. | |
| MX2015000179A (en) | Itraconazole compositions and dosage forms, and methods of using the same. | |
| MX2016006544A (en) | Withanolides useful for the treatment of neurodegenerative diseases. | |
| EP4385563A3 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
| MX2015013755A (en) | Pharmaceutical formulation for use in the treatment and/or prevention of restenosis. | |
| PH12016501811B1 (en) | Cosmetic composition for skin moisturizing containing minerals and quinoa extract | |
| MX2016002930A (en) | Liver x receptor (lxr) modulators. | |
| PH12016501658A1 (en) | Sialylated glycoprotein compositions and uses thereof | |
| MX365285B (en) | Lubricating complex for the mouth. | |
| HK1194912A2 (en) | Growth factor concentrate and the use thereof | |
| PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds |